Who's buying lunch: Are gifts to surgeons from industry bad for patients?

Thoracic Surgery Clinics

Volumn 15, Issue 4, 2005, Pages 533-542

  Grant, David C ^a   Iserson, Kenneth V ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2B INTERFERON; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CERIVASTATIN; EPTIFIBATIDE; GABAPENTIN; GOSERELIN; HYDROCHLOROTHIAZIDE; LORATADINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; ROFECOXIB; TROVAFLOXACIN; VASODILATOR AGENT;

ADVERTIZING; DEVICE; DRUG FATALITY; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE INDUSTRY; HEALTH CARE ORGANIZATION; HEALTH PROMOTION; HUMAN; INTERNAL MEDICINE; MARKETING; MEDICAID; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICARE; PHYSICIAN; PRIORITY JOURNAL; RACE; RESIDENCY EDUCATION; REVIEW; SURGEON;

DRUG INDUSTRY; ETHICS, MEDICAL; GIFT GIVING; HEALTH CARE SECTOR; HUMANS; PHYSICIAN-PATIENT RELATIONS; SURGERY;

EID: 25144497974     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2005.06.004     Document Type: Review

References (60)

1. R. Allman The relationship between physicians and the pharmaceutical industry: ethical problems with the every-day conflict of interest HEC Forum 15 2003 155 170
2. W. McKinney, D. Schiedermayer, and N. Lurie Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives JAMA 264 1990 1693 1697
3. M. Wilkes New York Times Magazine November 5, 1989 88 93
4. L. Jones Drug firms urged curb promotional gifts Am Med News 33 48 December 28, 1990 1
5. M. Bowman, and D. Pearle Changes in drug prescribing patterns related to commercial company funding of continuing medical education J Contin Educ Health Prof 8 1988 13 20
6. Sales forces, scripts up in 1999. Pharmaceutical Representative. Northfield (IL): Publisher Advanstar Communications. Accessed September 21, 2001
7. A. Wazana Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283 2000 373 380
8. D. Blumenthal Doctors and drug companies N Engl J Med 351 2004 1885 1890
9. A. Relman, and M. Angell America's other drug problem The New Republic 227 25 2002 27 41
10. L. Szabo Health systems cutting costs by closing door on drug reps USA Today 12B August 25, 2004
11. B. Hodges Interactions with the pharmaceutical industry CMAJ 153 1995 553 559
12. Access is worth its wait in gold Repertoire 11 10 2003 http://www.medicaldistribution.com/rep/Rep_2003_October/toc.htm
13. B. Spilker The benefits and risks of a pack of M&Ms: a pharmaceutical spokesman answers his industry's critics Health Aff (Millwood) 21 2002 243 244
14. B. Spilker The benefits and risks of a pack of M&Ms: a pharmaceutical spokesman answers his industry's critics Health Aff (Millwood) 21 2002 298 299
15. Committee on Labor and Human Resources Marketing, and promotional practices of the pharmaceutical industry 1991 US Government Printing Office Washington
16. E. Bricker Industrial marketing and medical ethics N Engl J Med 320 1989 1690 1692
17. American Medical Association Opinion E-8.061: clarifying addendum, 2004 Available at: http://www.ama-assn.org/ama/pub/category/4263.html Accessed February 4, 2005
18. D. Orentlicher Gifts to physicians from industry JAMA 265 1991 501
19. S. Goldfinger Physicians and the pharmaceutical industry Ann Intern Med 112 1990 624 626
20. Department of Veterans Health Affairs Business relationships between VHA staff and pharmaceutical industry representatives. VHA directive 2003-060 2003 US Government Printing Office Washington
21. B. Goodman No free lunch Available at: http://www.nofreelunch.org Accessed November 24, 2004
22. W. Rogers, P. Mansfield, and A. Braunack-Mayer The ethics of pharmaceutical industry relationships with medical students Med J Aust 180 2004 411 414
23. D. Studdert, M. Mello, and T. Brennan Financial conflicts of interest in physicians' relationships with the pharmaceutical industry self-regulation in the shadow of federal prosecution N Engl J Med 351 2004 1891 1900
24. Harris G. Guilty plea seen for drug maker. New York Times July 16, 2004;1,4
25. Harris G. As doctor writes prescription, drug company writes a check. New York Times. June 27, 2004;1,1
26. B. Ross, and D. Scott Influencing doctors: how pharmaceutical companies use enticement to "educate" physicians (ABCnews.com), 2002 Available at: http://www.vaccinationnews.com/DailyNews?February2002/InfluencingDoctors.htm Accessed February 21, 2002
27. Department of Health and Human Services OIG OIG compliance program guidance for pharmaceutical manufacturers Federal Register 68 2003 23731 23743
28. A. Relman Defending professional independence: ACCME's proposed new guidelines for commercial support of CME JAMA 289 2003 2418 2420
29. I. Macneil Exchange revisited: individual utility and social solidarity Ethics 96 1986 657 693
30. R. Belk It's the thought that counts: a signed digraph analysis of gift-giving J Consum Res 3 1976 155 162
31. J. Sherry Gift giving in anthropological perspective J Consum Res 10 1983 157 167
32. S. Coyle Physician-industry relations. Part 1: Individual physicians Ann Intern Med 136 2002 396 402
33. T. Randall Ethics of receiving gifts considered JAMA 265 1991 442 443
34. R.J. Blake, and E. Early Patients' attitudes about gifts to physicians from pharmaceutical companies J Am Board Fam Pract 8 1995 457 464
35. M. Chren, C. Landefeld, and T. Murray Doctors, drug companies, and gifts JAMA 262 1989 3448 3451
36. R. Gibbons, F. Landry, and D. Blouch A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts J Gen Intern Med 13 1998 151 154
37. M. Peay, and E. Peay The role of commercial sources in the adoption of a new drug Soc Sci Med 26 1988 1183 1189
38. A. Shaughnessy, and K. Bucci Drug samples and family practice residents Ann Pharmacother 31 1997 1296 1300
39. D. Morelli, and M. Koenigsberg Sample medication dispensing in a residency practice J Fam Pract 34 1992 42 48
40. E. Backer, J. Lebsack, and J. Reiner The value of pharmaceutical representative visits and medication samples in community-based family practices J Fam Pract 49 2000 811 816
41. F. Vrazo Hospitals get tough with drug firm reps (Philadelphia Inquirer) Available at: http://www.philly.com/mld/inquirer/9964610.htm?1c Accessed November 22, 2004
42. J. Banerji The gap is growing: more resources needed now for neglected diseases Available at: http://www.dndi.org/cms/public_html/insidearticleListing. asp?CategoryId=166&SubCategoryId=167&ArticleId=315&TemplateId=1 Accessed November 22, 2004
43. R. Davidson Source of funding and outcome of clinical trials J Gen Intern Med 1 1986 155 158
44. P. Rochon, J. Gurwitz, and R. Simms A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis Arch Intern Med 154 1994 157 163
45. M. Friedberg, B. Saffran, and T. Stinson Evaluation of conflict of interest in economic analyses of new drugs used in oncology JAMA 282 1999 1453 1457
46. T. Brennan Sounding board: buying editorials N Engl J Med 331 1994 673 675
47. J. Ross, P. Lurie, and S. Wolfe Concepts in professional education and communications. Why should you invest in medical education? Available at: http://www.citizen.org/publications/release.cfm?ID=6731 Accessed March 11, 2005
48. E. Johnson, and C. Jones Inside the business of medical ghostwriting (CBC News) Available at: http://www.cbc.ca/story/science/national/2002/10/24/ drug_res021024.html Accessed November 24, 2004
49. R. Sade Profits and professionalism J Thorac Cardiovasc Surg 123 2002 403 405
50. A. Mainous, W. Hueston, and E. Rich Patient perceptions of physician acceptance of gifts from the pharmaceutical industry Arch Fam Med 4 1995 335 339
51. M. Steinman, M. Shlipak, and S. McPhee Of principles and pens: attitudes and practices of medicine house staff toward pharmaceutical industry promotions Am J Med 110 2001 551 557
52. P. Palmisano, and J. Edelstein Teaching drug promotion abuses to health profession students J Med Educ 55 1980 453 455
53. A. Brett, W. Burr, and J. Moloo Are gifts from pharmaceutical companies ethically problematic? Arch Intern Med 163 2003 2213 2218
54. Barry P. Prescription drugs-the insiders. AARP Bulletin. November 2004;10-5
55. A. Bower, and G. Burkett Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices J Fam Pract 24 1987 612 616
56. T. Caudill, M. Johnson, and E. Rich Physicians, pharmaceutical sales representatives, and the cost of prescribing Arch Fam Med 5 1996 201 206
57. J. Avorn, M. Chen, and R. Hartley Scientific versus commercial sources of influence on the prescribing behavior of physicians Am J Med 73 1982 4 8
58. M. Ziegler, P. Lew, and B. Singer The accuracy of drug information from pharmaceutical sales representatives JAMA 273 1995 1296 1298
59. M. Chren, and C. Landefeld Physicians' behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital formulary JAMA 271 1994 684 689
60. J. Orlowski, and L. Wateska The effects of pharmaceutical firm enticements on physician prescribing patterns: there's no such thing as a free lunch Chest 102 1992 270 273